Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Family Practice | 10 | 2007 | 312 | 0.840 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2017 | 91 | 0.530 |
Why?
|
| Gout | 1 | 2014 | 9 | 0.500 |
Why?
|
| Uric Acid | 1 | 2014 | 37 | 0.490 |
Why?
|
| Vaccines | 1 | 2007 | 21 | 0.290 |
Why?
|
| Immunization Programs | 1 | 2007 | 25 | 0.280 |
Why?
|
| Efficiency, Organizational | 1 | 2007 | 61 | 0.280 |
Why?
|
| Electrosurgery | 4 | 1996 | 15 | 0.270 |
Why?
|
| Arthrodermataceae | 1 | 2003 | 4 | 0.220 |
Why?
|
| Dermatomycoses | 1 | 2003 | 17 | 0.220 |
Why?
|
| Skin Diseases | 2 | 1996 | 122 | 0.210 |
Why?
|
| Internship and Residency | 4 | 1998 | 596 | 0.210 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 1140 | 0.160 |
Why?
|
| Doxepin | 1 | 2017 | 5 | 0.150 |
Why?
|
| Melatonin | 1 | 2017 | 39 | 0.150 |
Why?
|
| Hypnotics and Sedatives | 1 | 2017 | 96 | 0.140 |
Why?
|
| Benzodiazepines | 1 | 2017 | 130 | 0.140 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1998 | 782 | 0.130 |
Why?
|
| Dermatology | 1 | 1996 | 75 | 0.120 |
Why?
|
| Gout Suppressants | 1 | 2014 | 7 | 0.120 |
Why?
|
| Patient Acuity | 1 | 2014 | 17 | 0.120 |
Why?
|
| Diet Therapy | 1 | 2014 | 22 | 0.120 |
Why?
|
| Work Capacity Evaluation | 1 | 1994 | 8 | 0.120 |
Why?
|
| Occupational Medicine | 1 | 1994 | 20 | 0.120 |
Why?
|
| Secondary Prevention | 1 | 2014 | 291 | 0.110 |
Why?
|
| Humans | 18 | 2017 | 68618 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2014 | 222 | 0.110 |
Why?
|
| Disease Management | 1 | 2014 | 248 | 0.110 |
Why?
|
| Headache | 1 | 2013 | 68 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 240 | 0.110 |
Why?
|
| Depression | 2 | 1998 | 943 | 0.100 |
Why?
|
| Niacin | 1 | 1992 | 12 | 0.100 |
Why?
|
| Flushing | 1 | 1992 | 7 | 0.100 |
Why?
|
| Ambulatory Care Facilities | 1 | 1992 | 91 | 0.100 |
Why?
|
| Pruritus | 1 | 1992 | 35 | 0.100 |
Why?
|
| Atrophic Vaginitis | 1 | 2011 | 1 | 0.100 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 2011 | 9 | 0.100 |
Why?
|
| Research | 1 | 1992 | 214 | 0.100 |
Why?
|
| Vaginosis, Bacterial | 1 | 2011 | 24 | 0.100 |
Why?
|
| Office Visits | 1 | 1991 | 83 | 0.100 |
Why?
|
| Trichomonas Vaginitis | 1 | 2011 | 25 | 0.090 |
Why?
|
| Aspirin | 1 | 1992 | 295 | 0.090 |
Why?
|
| Antifungal Agents | 2 | 2011 | 108 | 0.070 |
Why?
|
| Internal Medicine | 1 | 1988 | 118 | 0.070 |
Why?
|
| Forms and Records Control | 1 | 2007 | 16 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 2007 | 18 | 0.070 |
Why?
|
| Reminder Systems | 1 | 2007 | 39 | 0.070 |
Why?
|
| Documentation | 1 | 2007 | 83 | 0.070 |
Why?
|
| Critical Care | 1 | 1988 | 263 | 0.070 |
Why?
|
| Cervix Uteri | 2 | 1996 | 64 | 0.070 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 1996 | 44 | 0.070 |
Why?
|
| South Carolina | 5 | 1998 | 2752 | 0.060 |
Why?
|
| Sigmoidoscopy | 1 | 1985 | 38 | 0.060 |
Why?
|
| Risk Factors | 1 | 2014 | 5731 | 0.060 |
Why?
|
| Medical History Taking | 2 | 2013 | 94 | 0.050 |
Why?
|
| Hydroxides | 1 | 2003 | 5 | 0.050 |
Why?
|
| Potassium Compounds | 1 | 2003 | 7 | 0.050 |
Why?
|
| Physical Examination | 2 | 2013 | 152 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 1996 | 300 | 0.050 |
Why?
|
| Patients | 1 | 1982 | 69 | 0.050 |
Why?
|
| Referral and Consultation | 2 | 1996 | 383 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 848 | 0.040 |
Why?
|
| Adult | 7 | 2013 | 21403 | 0.040 |
Why?
|
| United States | 3 | 2007 | 7367 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 1998 | 3259 | 0.040 |
Why?
|
| Students, Medical | 1 | 1998 | 210 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 1996 | 100 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 1998 | 2279 | 0.030 |
Why?
|
| Confidentiality | 1 | 1994 | 62 | 0.030 |
Why?
|
| Female | 7 | 2011 | 38074 | 0.030 |
Why?
|
| Cluster Headache | 1 | 2013 | 3 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 1994 | 150 | 0.030 |
Why?
|
| Health Status | 1 | 1995 | 429 | 0.030 |
Why?
|
| Middle Aged | 5 | 1998 | 21147 | 0.030 |
Why?
|
| Migraine Disorders | 1 | 2013 | 66 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 1998 | 7277 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 1992 | 90 | 0.020 |
Why?
|
| Clinical Competence | 1 | 1996 | 657 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 658 | 0.020 |
Why?
|
| Gynecological Examination | 1 | 2011 | 2 | 0.020 |
Why?
|
| Vaginal Discharge | 1 | 2011 | 3 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2011 | 11 | 0.020 |
Why?
|
| Clindamycin | 1 | 2011 | 25 | 0.020 |
Why?
|
| Bacterial Load | 1 | 2011 | 24 | 0.020 |
Why?
|
| Safety | 1 | 1991 | 145 | 0.020 |
Why?
|
| Metronidazole | 1 | 2011 | 28 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 64 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1991 | 172 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1992 | 649 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 411 | 0.020 |
Why?
|
| Estrogens | 1 | 2011 | 173 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 618 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 166 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1995 | 824 | 0.020 |
Why?
|
| Male | 4 | 1998 | 37321 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 1992 | 1738 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1992 | 1342 | 0.020 |
Why?
|
| Mortality | 1 | 1988 | 163 | 0.020 |
Why?
|
| Colposcopy | 2 | 1996 | 20 | 0.020 |
Why?
|
| Papanicolaou Test | 2 | 1996 | 54 | 0.020 |
Why?
|
| Vaginal Smears | 2 | 1996 | 79 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 1026 | 0.010 |
Why?
|
| Biopsy | 2 | 1996 | 540 | 0.010 |
Why?
|
| Age Factors | 1 | 1988 | 1864 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 7029 | 0.010 |
Why?
|
| Time Factors | 1 | 1991 | 4655 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 1982 | 28 | 0.010 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 1982 | 10 | 0.010 |
Why?
|
| Demography | 1 | 1982 | 279 | 0.010 |
Why?
|
| Curriculum | 1 | 1985 | 575 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1982 | 384 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1982 | 955 | 0.010 |
Why?
|
| Aged | 2 | 1996 | 14862 | 0.010 |
Why?
|
| Primary Health Care | 1 | 1982 | 703 | 0.010 |
Why?
|
| Conization | 1 | 1995 | 3 | 0.010 |
Why?
|
| Life Style | 1 | 1995 | 338 | 0.010 |
Why?
|
| Adolescent | 2 | 1996 | 8912 | 0.010 |
Why?
|
| Smoking | 1 | 1995 | 1452 | 0.000 |
Why?
|